Bioventus (BVS) Total Debt Growth (3y) (2023 - 2026)
Bioventus (BVS) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 2.61% |
| 10 | Bioventus | 831.78 Mn | 795.94 Mn | 90.77 Mn | -15.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -15.16% |
| Dec 31, 2025 | -11.08% |
| Sep 27, 2025 | -8.74% |
| Jun 28, 2025 | -7.30% |
| Mar 29, 2025 | -4.66% |
| Dec 31, 2024 | -2.10% |
| Sep 28, 2024 | 29.30% |
| Jun 29, 2024 | 26.14% |
| Mar 30, 2024 | 28.42% |
| Dec 31, 2023 | 27.98% |